Clinical Trial Update: SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF

View source ↗

Summary

A clinical trial update reports SVR12 results for genotype 3 hepatitis C treated with remdesivir plus sofosbuvir; the study is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Remdesivir (remdesivir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Center of target therapy | Conditions: Viral Hepatitis C | Status: ACTIVE_NOT_RECRUITING